1-4 of 4
Erin Stebner
Close
Sort by
Journal Articles

Bortezomib-induced “BRCAness” sensitizes multiple myeloma cells to PARP inhibitors

Paola Neri, Li Ren, Kathy Gratton, Erin Stebner, Jordan Johnson, Alexander Klimowicz, Peter Duggan, Pierfrancesco Tassone, Adnan Mansoor, Douglas A. Stewart, Sagar Lonial, Lawrence H. Boise, Nizar J. Bahlis
Journal: Blood
Blood (2011) 118 (24): 6368–6379.
https://doi.org/10.1182/blood-2011-06-363911
Published: 2011
Includes: Supplemental data
Journal Articles

Mir-34a Sensitizes Multiple Myeloma (MM) Cells to the Proteasome Inhibitor Bortezomib

Erin Stebner, Paola Neri, MD, PhD, Jordan Johnson, Kathy J Gratton, Li Ren, PhD, Peter Duggan, MD, FRCPC, Douglas A. Stewart, MD, FRCP, Nizar Bahlis, MD
Journal: Blood
Blood (2011) 118 (21): 138.
https://doi.org/10.1182/blood.V118.21.138.138
Published: 2011
Journal Articles

Bortezomib Impairs Myeloma Cells (MM) Homologous Recombination Through Inhibition of the E2-Ubiquitin-Conjugating Enzyme UBC13

Paola Neri, MD, PhD, Li Ren, PhD, Jordan Johnson, Kathy J Gratton, Erin Stebner, Carolyn J Owen, MD, FRCPC, Peter Duggan, MD, FRCPC, Douglas A. Stewart, MD, FRCP, Nizar Bahlis, MD
Journal: Blood
Blood (2011) 118 (21): 1834.
https://doi.org/10.1182/blood.V118.21.1834.1834
Published: 2011
Journal Articles

Bortezomib Induced BRCAness Sensitizes Multiple Myeloma Cells to PARP Inhibitors

Paola Neri, MD, PhD, Li Ren, PhD, Kathy Gratton, Erin Stebner, Carolyn J Owen, MD, FRCPC, Peter Duggan, MD, FRCPC, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Douglas A. Stewart, MD, FRCP, Nizar J Bahlis, MD
Journal: Blood
Blood (2010) 116 (21): 789.
https://doi.org/10.1182/blood.V116.21.789.789
Published: 2010